Avalo Therapeutics, Inc. AVTX
Revenue compounded at −61.2% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity lost 72 cents this year.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
| Operating income $B | −0.1 | −0.1 | −0.0 | −0.0 | −0.1 | −0.1 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.1 | −0.1 | −0.0 | −0.0 | −0.1 | −0.1 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | · | · |
| Net income $B | −0.1 | −0.0 | −0.0 | −0.0 | −0.1 | −0.1 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | · | · | · | −0.0 | −0.1 | −0.0 | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −5.84 | −20.91 | −113.58 | · | · | · | · | −1.20 | 0.42 | −1.87 | −4.71 | −5.48 | −20.72 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −72.4 | −50.1 | · | −684.8 | −354.2 | −278.8 | −76.7 | −164.3 | 84.6 | −247.9 | · | · | · |
| Shares out B | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.08 | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | 0.00 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 12 of 19 fiscal years. 1 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 40 checks could not be computed.